{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T20:49:01Z","timestamp":1696279741250},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1097\/jan.0000000000000014","type":"journal-article","created":{"date-parts":[[2014,3,10]],"date-time":"2014-03-10T13:08:21Z","timestamp":1394456901000},"page":"16-25","source":"Crossref","is-referenced-by-count":4,"title":["The Baltimore Buprenorphine Initiative"],"prefix":"10.1097","volume":"25","author":[{"given":"Lyn Stankiewicz","family":"Murphy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marla T.","family":"Oros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan G.","family":"Dorsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"3","key":"R2-4-20210126","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10550887.2012.694598","article-title":"Maintenance medication for opiate addiction: The foundation of recovery.","volume":"31","author":"Bart","year":"2012","journal-title":"Journal of Addictive Diseases"},{"key":"R3-4-20210126","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/0959523021000023180","article-title":"Characteristics, retention, and readmission of opioid-dependent clients treated with oral naltrexone.","volume":"21","author":"Bartu","year":"2002","journal-title":"Drug and Alcohol Review"},{"issue":"2","key":"R4-4-20210126","first-page":"93","article-title":"Buprenorphine in the treatment of heroin addiction.","volume":"25","author":"Bell","year":"2012","journal-title":"The Journal of Psychiatry and Neurological Sciences"},{"key":"R5-4-20210126","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1360-0443.2009.02627.x","article-title":"Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment.","volume":"104","author":"Bell","year":"2009","journal-title":"Addiction"},{"key":"R6-4-20210126","first-page":"250","article-title":"Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential Molecular N","volume":"44","author":"Blum","year":"2011","journal-title":"eurobiology"},{"issue":"7-8","key":"R7-4-20210126","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0027-9684(15)30175-9","article-title":"Opioid addiction and abuse in primary care practice: A comparison of methadone and buprenorphine as treatment options.","volume":"104","author":"Bonhomme","year":"2012","journal-title":"Journal of the National Medical Association"},{"issue":"1","key":"R8-4-20210126","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1081\/ADA-100100592","article-title":"Symptoms of dependence, multiple substance use, and labor market outcomes.","volume":"26","author":"Bray","year":"2000","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"3","key":"R9-4-20210126","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/002204261004000302","article-title":"Exploring the relationship between access and retention among substance abuse treatment admissions.","volume":"40","author":"Brucker","year":"2010","journal-title":"Journal of Drug Issues"},{"issue":"12-13","key":"R10-4-20210126","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1081\/JA-120014424","article-title":"Factors associated with completion of a drug treatment court diversion program.","volume":"37","author":"Butzin","year":"2002","journal-title":"Substance Use Misuse"},{"issue":"1","key":"R12-4-20210126","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/02791072.2002.10399938","article-title":"Predictors of attrition in a longitudinal study of substance abusers.","volume":"34","author":"Claus","year":"2002","journal-title":"Journal of Psychoactive Drugs"},{"key":"R13-4-20210126","doi-asserted-by":"crossref","first-page":"ES231","DOI":"10.36076\/ppj.2012\/15\/ES231","article-title":"Office-based opioid dependence treatment.","volume":"15","author":"Colson","year":"2012","journal-title":"Pain Physician"},{"issue":"2","key":"R14-4-20210126","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/10550490701860971","article-title":"Long-term treatment with buprenorphine-naloxone in primary care: Results at 2-5 years.","volume":"17","author":"Fiellin","year":"2008","journal-title":"American Journal of Additions"},{"issue":"4","key":"R15-4-20210126","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3109\/10884600903290424","article-title":"Buprenorphine prescribing: Why physicians arent and nurse prescribers cant.","volume":"20","author":"Fornili","year":"2009","journal-title":"Journal of Addictions Nursing"},{"key":"R16-4-20210126","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1081\/ADA-200032290","article-title":"Effectiveness of long-term residential substance abuse treatment for women: Findings from three national studies.","volume":"30","author":"Greenfield","year":"2004","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"R17-4-20210126","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1360-0443.2011.03676.x","article-title":"The effectiveness of opioid maintenance treatment in prison settings: A systemic review.","volume":"107","author":"Hedrich","year":"2011","journal-title":"Addiction"},{"issue":"2","key":"R18-4-20210126","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/02791072.2011.587704","article-title":"Integrating buprenorphine treatment into a public healthcare system: The San Francisco Department of Public Healths office-based buprenorphine pilot program.","volume":"43","author":"Hersh","year":"2011","journal-title":"Journal of Psychoactive Drugs"},{"issue":"4","key":"R19-4-20210126","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1037\/0893-164X.11.4.261","article-title":"Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS).","volume":"11","author":"Hubbard","year":"1997","journal-title":"Psychology of Addictive Behaviors"},{"issue":"1-3","key":"R21-4-20210126","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugalcdep.2008.07.013","article-title":"Cost analysis of clinic and office-based treatment of opioid dependence: Results with methadone and buprenorphine in clinically stable patients.","volume":"99","author":"Jones","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"R22-4-20210126","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0740-5472(03)00210-1","article-title":"Client-related predictors of early treatment drop-out in a substance abuse clinic exclusively employing individual therapy.","volume":"26","author":"King","year":"2004","journal-title":"Journal of Substance Abuse Treatment"},{"key":"R23-4-20210126","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/00005053-198310000-00003","article-title":"Concurrent validity of the Addiction Severity Index.","volume":"171","author":"Kosten","year":"1983","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"2","key":"R25-4-20210126","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/002204269602600208","article-title":"Maturing out of substance use: Selection and self-correction.","volume":"26","author":"Labouvie","year":"1996","journal-title":"Journal of Drug Issues"},{"issue":"13-14","key":"R26-4-20210126","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1081\/JA-200034729","article-title":"Employment, employment-related problems, and drug use at the drug court entry.","volume":"39","author":"Leukefeld","year":"2004","journal-title":"Substance Use Misuse"},{"key":"R27-4-20210126","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/02791072.2000.10400232","article-title":"Correlates of outpatient drug treatment drop-out among methamphetamine users.","volume":"32","author":"Maglione","year":"2003","journal-title":"Journal of Psychoactive Drugs"},{"key":"R28-4-20210126","doi-asserted-by":"crossref","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","article-title":"Opioid epidemic in the United States.","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"issue":"3","key":"R29-4-20210126","first-page":"CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"R30-4-20210126","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10550490500528316","article-title":"The Addiction Severity Index at 25: Origins, contributions and transitions.","volume":"1","author":"McLellan","year":"2006","journal-title":"The American Journal on Addictions"},{"key":"R31-4-20210126","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00005053-198507000-00005","article-title":"New data from the Addiction Severity Index: Reliability and validity in three centers.","volume":"173","author":"McLellan","year":"1985","journal-title":"Journal of Nervous and Mental Disease"},{"key":"R33-4-20210126","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/10550490903077820","article-title":"Uses of diverted methadone and burprenorphine by opioid-addicted individuals in Baltimore, Maryland.","volume":"18","author":"Mitchell","year":"2009","journal-title":"The American Journal on Addictions"},{"issue":"3","key":"R34-4-20210126","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1360-0443.2003.00327.x","article-title":"Long-term influence of durance and intensity of treatment on previously untreated individuals with alcohol use disorders.","volume":"98","author":"Moos","year":"2003","journal-title":"Addictions"},{"key":"R35-4-20210126","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1465-3362.2009.00050.x","article-title":"Predictors of 3-month retention in a drug treatment therapeutic community.","volume":"28","author":"Mulder","year":"2009","journal-title":"Drug and Alcohol Review"},{"key":"R36-4-20210126","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1176\/ps.49.1.68","article-title":"Outcomes of homeless mentally ill chemical abusers in community residences and a therapeutic community.","volume":"49","author":"Nuttbrock","year":"1998","journal-title":"Psychiatric Services"},{"key":"R37-4-20210126","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1745-7599.2011.00656.x","article-title":"Nurse practitioners inability to prescribe buprenorphine: Limitations of the Drug Addiction Treatment Act of 2000.","volume":"23","author":"OConner","year":"2011","journal-title":"Journal of the American Academy of Nursing Practitioners"},{"issue":"3","key":"R38-4-20210126","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.drugalcdep.2011.10.004","article-title":"Receipt of opioid agonist treatment in the Veterans Health Administration: Facility and patient factors.","volume":"122","author":"Oliva","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"key":"R39-4-20210126","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/00019442-200211000-00013","article-title":"Alcoholism treatment adherence: Older age predicts better adherence and drinking outcomes.","volume":"10","author":"Oslin","year":"2002","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"R40-4-20210126","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.drugalcdep.2009.07.013","article-title":"Long-term outcomes of office-based buprenorphinenaloxone maintenance therapy.","volume":"106","author":"Parran","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"R42-4-20210126","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jsat.2010.07.009","article-title":"The SUMMIT trial: A field comparison of buprenorphine versus methadone maintenance treatment.","volume":"39","author":"Pinto","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"key":"R43-4-20210126","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1360-0443.2004.00831.x","article-title":"Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program.","volume":"99","author":"Satre","year":"2004","journal-title":"Addiction"},{"key":"R44-4-20210126","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0376-8716(02)00192-8","article-title":"Predictors of drug abuse treatment entry among crack-cocaine smokers.","volume":"68","author":"Siegal","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"key":"R45-4-20210126","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0740-5472(95)90009-8","article-title":"Client engagement and change during drug abuse treatment.","volume":"7","author":"Simpson","year":"1995","journal-title":"Journal of Substance Abuse Treatment"},{"key":"R46-4-20210126","doi-asserted-by":"crossref","first-page":"400","DOI":"10.15288\/jsad.2010.71.400","article-title":"Reasons for quitting among emerging adults and adolescents in substance-use-disorder treatment.","volume":"10","author":"Smith","year":"2010","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"R47-4-20210126","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jsat.2009.08.001","article-title":"Home- versus office-based buprenorphine inductions for opioid-dependent patients.","volume":"38","author":"Sohler","year":"2010","journal-title":"Journal of Substance Abuse Treatments"},{"issue":"3","key":"R48-4-20210126","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/10550887.2012.694603","article-title":"Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: The need to expand access to buprenorphinenaloxone in marginalized populations.","volume":"31","author":"Stancliff","year":"2012","journal-title":"Journal of Addictive Diseases"},{"key":"R49-4-20210126","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.drugalcdep.2011.10.016","article-title":"The impact of buprenorphine of treatment of opioid dependence in a Medicaid population: Recent service utilization trends in the use of buprenorphine and methadone.","volume":"123","author":"Stein","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"1-2","key":"R50-4-20210126","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/10884602.2010.545090","article-title":"Buprenorphine clinic for opioid maintenance therapy: Program description, process measures, and patient satisfaction.","volume":"22","author":"Strobbe","year":"2011","journal-title":"Journal of Addictions Nursing"},{"key":"R53-4-20210126","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1348\/0007110042307203","article-title":"On the correlation of a naturally and an artificially dichotomized variable.","volume":"57","author":"Ulrich","year":"2004","journal-title":"The British Journal of Mathematical and Statistical Psychology"},{"issue":"3","key":"R55-4-20210126","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11414-008-9128-0","article-title":"Program characteristics and the length of time clients are in substance abuse treatment.","volume":"36","author":"Walker","year":"2009","journal-title":"The Journal of Behavioral Health Services Research"},{"issue":"9","key":"R56-4-20210126","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s11606-008-0686-x","article-title":"Office-based management of opioid dependence with buprenorphine: Clinical practices and barriers.","volume":"23","author":"Walley","year":"2008","journal-title":"Journal of General Internal Medicine"},{"issue":"2","key":"R57-4-20210126","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1037\/a0023031","article-title":"Interaction effects of age an contingency management treatments in cocaine-dependent outpatients.","volume":"19","author":"Weis","year":"2011","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"R58-4-20210126","first-page":"1","article-title":"Maturing out of narcotic addiction.","volume":"14","author":"Winick","year":"1962","journal-title":"Bulletin on Narcotics"}],"container-title":["Journal of Addictions Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JAN.0000000000000014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T15:27:50Z","timestamp":1648567670000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00060867-201401000-00004"}},"subtitle":["Understanding the Role of Buprenorphine in Addressing Heroin Addiction in an Urban-Based Community"],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/jan.0000000000000014","relation":{},"ISSN":["1088-4602"],"issn-type":[{"value":"1088-4602","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}